{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:33:27Z","timestamp":1784745207580,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00198-010-1274-6","type":"journal-article","created":{"date-parts":[[2010,5,10]],"date-time":"2010-05-10T14:50:45Z","timestamp":1273503045000},"page":"21-26","source":"Crossref","is-referenced-by-count":67,"title":["Oral bisphosphonate compliance and persistence: a matter of choice?"],"prefix":"10.1007","volume":"22","author":[{"given":"S. L.","family":"Silverman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. T.","family":"Schousboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. T.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,11]]},"reference":[{"key":"1274_CR1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","volume":"18","author":"JA Cramer","year":"2007","unstructured":"Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18:1023\u20131031","journal-title":"Osteoporos Int"},{"key":"1274_CR2","unstructured":"Silverman SL, Cramer JA, Sunyecz JA, et al (2007) Women are more persistent with monthly bisphosphonate therapy compared to weekly bisphosphonates: 12\u00a0month results from two retrospective databases. Presented at ASBMR Montreal, 19 Sept 2007. Abstract W366"},{"issue":"1","key":"1274_CR3","first-page":"125","volume":"29","author":"FE Cotte","year":"2009","unstructured":"Cotte FE, Fardelione P, Mercier F, Gaudin AF, Roux C (2009) Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int 29(1):125\u2013139","journal-title":"Osteoporos Int"},{"issue":"12","key":"1274_CR4","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1185\/030079906X154042","volume":"22","author":"DT Gold","year":"2006","unstructured":"Gold DT, Safi W, Trinh H (2006) Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate. Curr Med Res Opin 22(12):2383\u20132391","journal-title":"Curr Med Res Opin"},{"key":"1274_CR5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00774-009-0112-4","volume":"28","author":"I Gorai","year":"2010","unstructured":"Gorai I, Tanaka Y, Hattori S, Iwaoki Y (2010) Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene or alfacalcidol in postmenopausal Japanese women. J Bone Miner Metab 28:176\u2013184","journal-title":"J Bone Miner Metab"},{"key":"1274_CR6","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00198-006-0171-5","volume":"17","author":"NK Arden","year":"2006","unstructured":"Arden NK, Earl S, Fisher DJ et al (2006) Persistence with teriparitide in patients with osteoporosis: the UK experience. Osteoporos Int 17:1626\u20131629","journal-title":"Osteoporos Int"},{"issue":"7653","key":"1274_CR7","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","volume":"336","author":"B Vrijens","year":"2008","unstructured":"Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M (2008) Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 336(7653):1114\u20131117","journal-title":"BMJ"},{"key":"1274_CR8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","volume":"288","author":"CA Jackevicius","year":"2002","unstructured":"Jackevicius CA, Mamdani M, Tu JV (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288:462\u2013467","journal-title":"JAMA"},{"key":"1274_CR9","unstructured":"Boston Consulting Group (BCG) (2002) Analysis: Harris interactive 10,000 patient survey 2002. Available at: http:\/\/www.bcg.com\/documents\/file14265.pdf . Accessed: 21 Oct 2009"},{"issue":"2 Suppl 2","key":"1274_CR10","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.bone.2005.11.013","volume":"38","author":"JY Reginster","year":"2006","unstructured":"Reginster JY (2006) Adherence and persistence: impact and outcomes and health care resources. Bone 38(2 Suppl 2):S18\u2013S21","journal-title":"Bone"},{"key":"1274_CR11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00198-003-1502-4","volume":"14","author":"RA Yood","year":"2003","unstructured":"Yood RA, Emani S, Reed JI, Lewis BE, Charpentier M, Lydick E (2003) Compliance with pharmacologic therapy for osteoporosis. Osteoporos Int 14:965\u2013968","journal-title":"Osteoporos Int"},{"key":"1274_CR12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00198-006-0230-y","volume":"18","author":"D Weycker","year":"2007","unstructured":"Weycker D, Macarios D, Edelsberg J, Oster G (2007) Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int 18:271\u2013277","journal-title":"Osteoporos Int"},{"key":"1274_CR13","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bone.2005.10.022","volume":"38","author":"KF Huybrechts","year":"2006","unstructured":"Huybrechts KF, Ishak KJ, Caro JJ (2006) Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 38:922\u2013928","journal-title":"Bone"},{"key":"1274_CR14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-007-0506-x","volume":"19","author":"V Rabenda","year":"2008","unstructured":"Rabenda V, Mertens R, Fabri V, Vanoverloop J, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY (2008) Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 19:811\u2013818","journal-title":"Osteoporos Int"},{"key":"1274_CR15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00198-004-1652-z","volume":"15","author":"JJ Caro","year":"2004","unstructured":"Caro JJ, Ishak KJ, Kf H, Raggio G, Naujoks C (2004) The impact of compliance with osteoporosis therapies on fracture rates in actual practice. Osteoporos Int 15:1003\u20131008","journal-title":"Osteoporos Int"},{"key":"1274_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","volume":"48","author":"JS McCombs","year":"2004","unstructured":"McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J (2004) Compliance with drug therapies for the prevention and treatment of osteoporosis. Maturitas 48:271\u2013287","journal-title":"Maturitas"},{"key":"1274_CR17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","volume":"81","author":"ES Siris","year":"2006","unstructured":"Siris ES, Harris ST, Cj R, Barr CE, Arvesen JN, Abbott TA, Silverman S (2006) Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81:1013\u20131022","journal-title":"Mayo Clin Proc"},{"key":"1274_CR18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1359\/jbmr.080418","volume":"23","author":"JR Curtis","year":"2008","unstructured":"Curtis JR, Westfall AO, Cheng H, Lyles k, Saag K, Delzell E (2008) Benefit of adherence with bisphosphonates depends on the age and fracture type: results from an analysis of 101,038 new bisphosphonate users. J Bone Miner Res 23:1435\u20131441","journal-title":"J Bone Miner Res"},{"key":"1274_CR19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bone.2008.09.006","volume":"44","author":"A Feldstein","year":"2009","unstructured":"Feldstein A (2009) Effectiveness of bisphosphonate therapy in a community setting. Bone 44:153\u2013159","journal-title":"Bone"},{"issue":"2","key":"1274_CR20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11926-008-0021-x","volume":"10","author":"SL Silverman","year":"2008","unstructured":"Silverman SL, Gold DT (2008) Compliance and persistence with osteoporosis therapies. Curr Rheumatol Rep 10(2):118\u2013122","journal-title":"Curr Rheumatol Rep"},{"key":"1274_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.maturitas.2004.05.004","volume":"50","author":"RR Cline","year":"2005","unstructured":"Cline RR, Farley JF, Hansen RA, Schommer JC (2005) Osteoporosis beliefs and antiresorptive medication use. Maturitas 50:196\u2013208","journal-title":"Maturitas"},{"key":"1274_CR22","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1185\/030079907X242890","volume":"23","author":"CA McHorney","year":"2007","unstructured":"McHorney CA, Schousboe JT, Cline RR, Weiss TW (2007) The impact of osteoporosis medication beliefs and side effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin 23:3137\u20133152","journal-title":"Curr Med Res Opin"},{"key":"1274_CR23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00198-003-1393-4","volume":"14","author":"Y Liel","year":"2003","unstructured":"Liel Y, Castel H, Bonneh DY (2003) Impact of subsidizing effective anti-osteoporosis drugs on compliance with management guidelines in patients following low impact fractures. Osteoporos Int 14:490\u2013495","journal-title":"Osteoporos Int"},{"key":"1274_CR24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00198-007-0535-5","volume":"19","author":"EW Bekker-Grob de","year":"2008","unstructured":"de Bekker-Grob EW, Essink-Bot ML, Meerding WJ, Pols HAP, Koes BW, Steyerberg EW (2008) Patients\u2019 preferences for osteoporosis drug treatment: a discrete choice experiment. Osteoporos Int 19:1029\u20131037","journal-title":"Osteoporos Int"},{"key":"1274_CR25","first-page":"1086","volume":"32","author":"L Fraenkel","year":"2006","unstructured":"Fraenkel L, Constantinescu F, Oberto Medina M, Wittink DR (2006) Womens preferences for prevention of bone loss. J Rheumatol 32:1086\u20131092","journal-title":"J Rheumatol"},{"key":"1274_CR26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1475-6773.2009.00989.x","volume":"44","author":"AJ Karter","year":"2009","unstructured":"Karter AJ, Parker MM, Moffet HH, Ahmed AT, Ja S, Selby JV (2009) New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res 44:1445\u20131448","journal-title":"Health Serv Res"},{"key":"1274_CR27","first-page":"163","volume-title":"Predicting health behavior","author":"R Schwarzer","year":"1995","unstructured":"Schwarzer R, Fuchs R (1995) Self-efficacy and health behaviors. In: Connor M, Norman P (eds) Predicting health behavior. Open University Press, Philadelphia, pp 163\u2013196"},{"key":"1274_CR28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00198-005-0010-0","volume":"17","author":"V Carnevale","year":"2006","unstructured":"Carnevale V, Nieddu L, Romagnoli E, Bona E, Piemonte S, Scillitani A, Minisola S (2006) Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian study. Osteoporos Int 17:478\u2013483","journal-title":"Osteoporos Int"},{"issue":"3","key":"1274_CR29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1017\/S0266462300008667","volume":"11","author":"JL Donovan","year":"1995","unstructured":"Donovan JL (1995) Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care 11(3):443\u2013455","journal-title":"Int J Technol Assess Health Care"},{"key":"1274_CR30","volume-title":"The adherence gap: why osteoporosis patients don\u2019t continue with treatment","author":"International Osteoporosis Foundation","year":"2005","unstructured":"International Osteoporosis Foundation (2005) The adherence gap: why osteoporosis patients don\u2019t continue with treatment. Nyon, Switzerland"},{"key":"1274_CR31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","volume":"89","author":"JA Clowes","year":"2004","unstructured":"Clowes JA, Peel NF, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89:1117\u20131123","journal-title":"J Clin Endocrinol Metab"},{"key":"1274_CR32","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2006-1526","volume":"92","author":"PD Delmas","year":"2007","unstructured":"Delmas PD, Vrijens B, Eastell R, Roux C, Pois HA, Ringe JD, Grauer A, Cahall D, Watts NB, Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators (2007) Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 92:1296\u20131304","journal-title":"J Clin Endocrinol Metab"},{"key":"1274_CR33","doi-asserted-by":"crossref","unstructured":"Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X (2008) Interventions for enhancing medication adherence. Cochrane Database Syst Rev 16(2):CD000011","DOI":"10.1002\/14651858.CD000011.pub3"},{"key":"1274_CR34","author":"T Gleeson","year":"2009","unstructured":"Gleeson T, Iversen MD, Avorn J, Brookhart AM, Katz JN, Losina E, May F, Patrick AR, Shrank WH, Solomon DH (2009) Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int. doi: 10.1007\/s00198-009-0976-0","journal-title":"Osteoporos Int"},{"key":"1274_CR35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"DE Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10:348\u2013354","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1274_CR36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MLR.0b013e31818afa1c","volume":"47","author":"JR Curtis","year":"2009","unstructured":"Curtis JR, Xi J, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E (2009) Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care 47:334\u2013341","journal-title":"Med Care"},{"key":"1274_CR37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1331\/JAPhA.2008.07040","volume":"48","author":"PJ Schneider","year":"2003","unstructured":"Schneider PJ, Murphy JE, Pedersen CA (2003) Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc 48:58\u201363","journal-title":"J Am Pharm Assoc"},{"key":"1274_CR38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijmedinf.2008.07.011","volume":"78","author":"M Cocosila","year":"2009","unstructured":"Cocosila M, Archer N, Haynes RB, Yuan Y (2009) Can wireless text messaging improve adherence to preventive activities? Results of a randomized controlled trial. Int J Med Inform 78:230\u2013238","journal-title":"Int J Med Inform"},{"key":"1274_CR39","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/tmj.2009.0033","volume":"15","author":"TL Hayes","year":"2009","unstructured":"Hayes TL, Cobbinah K, Dishongh T, Kaye JA, Kimel J, Labhard M, Leen T, Lundell J, Ozertem U, Pvael M, Phillipose M, Rhodes K, Vurgun S (2009) A study of medication taking and unobtrusive, intelligent reminding. Telemed J E Health 15:770\u2013776","journal-title":"Telemed J E Health"},{"key":"1274_CR40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2337\/diacare.28.2.278","volume":"28","author":"RJ Young","year":"2005","unstructured":"Young RJ, Taylor J, Friede T, Hollis S, Mason JM, Lee P, Burns E, Long AF, Gambling T, New JP, Gibson JM (2005) Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial. Diabetes Care 28:278\u2013282","journal-title":"Diabetes Care"},{"key":"1274_CR41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/BOR.0b013e32832c6aa4","volume":"21","author":"AH Warriner","year":"2009","unstructured":"Warriner AH, Curtis JR (2009) Adherence to osteoporosis treatments: room for improvement. Curr Opin Rheumatol 21:356\u2013362","journal-title":"Curr Opin Rheumatol"},{"key":"1274_CR42","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1742-1241.2006.01059.x","volume":"60","author":"A Cooper","year":"2006","unstructured":"Cooper A, Drake J, Brankin E, PERSIST Investigators (2006) Treatment persistence withonce-monthly ibandronate and patient support vs once weekly alendronate: results from the PERSIST trial. Int J Clin Pract 60:896\u2013905","journal-title":"Int J Clin Pract"},{"key":"1274_CR43","volume-title":"Motivational interviewing: preparing people for change","author":"WR Miller","year":"2002","unstructured":"Miller WR, Rollnick S (2002) Motivational interviewing: preparing people for change. Guilford Press, New York"},{"key":"1274_CR44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00005053-199910000-00007","volume":"187","author":"AJ Swanson","year":"1999","unstructured":"Swanson AJ, Pantalon MV, Cohen KR (1999) Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. J Nerv Ment Disease 187:630\u2013635","journal-title":"J Nerv Ment Disease"},{"key":"1274_CR45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/0272989X08318461","volume":"29","author":"FE Cotte","year":"2009","unstructured":"Cotte FE, Fautrel B, Pouvourville G De (2009) A Markov model simulation of the effect of treatment persistence in postmenopausal osteoporosis. Med Decis Making 29:125\u2013139","journal-title":"Med Decis Making"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00198-010-1274-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T14:49:55Z","timestamp":1551365395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1274-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,11]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1274-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,11]]}}}